SMJ articles in the category "telithromycin"

Original Article

Telithromycin for the Treatment of Acute Bacterial Maxillary Sinusitis: A Review of a New Antibacterial Agent

Objective: Telithromycin, the first approved ketolide antibiotic, was developed to treat community-acquired respiratory tract infections, including acute bacterial maxillary sinusitis (ABMS). A previously published study showed that a 5-day course of 800 mg telithromycin once daily is as effective as a 10-day course in the treatment of ABMS. Materials and…

Posted in: sinusitis 5 telithromycin 2

Original Article

Antimicrobial Resistance among Isolates of Respiratory Tract Infection Pathogens from the Southern United States: Data from the PROTEKT US Surveillance Program 2000/2001

Background PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin in the United States) was established in 2000 to monitor antimicrobial resistance among respiratory tract pathogens across the United States. Methods During 2000 to 2001, 75 southern US centers collected 3,867 Streptococcus pneumoniae, 1,455 Streptococcus pyogenes and…

Posted in: resistance 3 southern United States 3 telithromycin 2
SMA Menu